Lawrence Lesko, former director of the Office of Clinical Pharmacology at the US Food and Drug Administration’s Center for Drug Evaluation and Research, has joined MolecularHealth as a scientific advisor.
Lesko retired from his post at the FDA in June 2011 after nearly 20 years at the agency. He joined University of Florida's Medical City campus in Lake Nona last July as the director of the Center for Pharmacometrics and Systems Pharmacology.
Lesko will help the firm refine its drug safety assessment and prediction platform, called Molecular Analysis of Side Effects.
The FDA is in the process of evaluating MASE to figure out how it can use the software to predict drug safety issues in the post-market setting (PGx Reporter 2/15/2012).